产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
R873399 | 204935-85-3 | (2R,3R)-3,7,4'-三羟基-5-甲氧基-8-异戊烯基二氢黄酮, ≥98% (2R,3R)-3,7,4'-Trihydroxy-5-methoxy-8-prenylflavanone, ≥98% |
C21H22O6 | |
A938426 | 243975-37-3 | (2R,5S,8S,11S,15S)-5-[3-[[amino-(methylcarbamoylamino)methylidene]amino]propyl]-8-benzyl-2,7-dimethyl-3,6,9,13,17-pentaoxo-1,4,7,10,14-pentazacycloheptadecane-11,15-dicarboxylic acid, ≥98% Argifin, ≥98% |
C29H41N9O10 | |
C920925 | 149184-22-5 | (2S)-3-[[(1S)-1-(3,4-二氯苯基)乙基] 氨基-2-羟基丙基](苯甲基)次膦酸 盐酸盐, 98% (HPLC) CGP 55845 hydrochloride, 98% (HPLC) |
C18H22Cl2NO3P · HCl | |
S882166 | 149709-63-7 | (2S,4S)-Sacubitril , 98% (2S,4S)-Sacubitril , 98% |
C24H29NO5 | |
D937665 | 1173715-42-8 | (2z)-N-(biphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide, ≥99% hDHODH-IN-1 , ≥99% |
C17H14N2O2 | |
I936932 | 667463-82-3 | (2Z,3E)-3-(羟基亚氨基)-[2,3'-联吲哚啉亚基]-2'-酮, ≥98% Indirubin-3′-oxime, ≥98% |
C16H11N3O2 | |
H872188 | 951654-29-8 | (3-5-(1-羟基-1-甲基乙基)-1H-苯并咪唑-1-基][1,1'-联苯基]-2-甲酰胺, 98% 3'-[5-(1-Hydroxy-1-methylethyl)-1H-benzimidazol-1-yl][1,1'-biphenyl]-2-carboxamide, 98% |
C23H21N3O2 | |
R793501 | 919091-63-7 | (3E, 5E)-3, 5-双(4-硝基亚苄基)哌啶-4-酮, 10mM in DMSO RA-9, 10mM in DMSO |
C19H15N3O5 | |
R937666 | 919091-63-7 | (3E,5E)-3,5-双(4-硝基亚苄基)哌啶-4-酮, ≥98% RA-9, ≥98% |
C19H15N3O5 | |
P937797 | 136259-20-6 | (3N-[(2S,3S)-2-AMINO-3-METHYL-PENTANOYL]-1,3-THIAZOLIDINE) HEMIFUMARATE, ≥98% P32/98, ≥98% |
C9H18N2OS | |
R937467 | 1359752-95-6 | (3R,4R)-A2-32-01, ≥99% (3R,4R)-A2-32-01, ≥99% |
C19H27NO2 | |
O937893 | 1191921-01-3 | (3R,4R,5S)-4,5-二乙酰氨基-3-(戊-3-基氧基)环己-1-烯羧酸乙酯, ≥98% Oseltamivir-acetate, ≥98% |
C18H30N2O5 | |
O793730 | 204255-11-8 | (3R,4R,5S)-4-乙酰氨基-5-氨基-3-(戊-3-基氧基)环己-1-烯羧酸乙酯磷酸盐, 2mM in DMSO (3R,4R,5S)-4-乙酰氨基-5-氨基-3-(戊-3-基氧基)环己-1-烯羧酸乙酯磷酸盐, 2mM in DMSO |
C16H31N2O8P | |
S937976 | 254452-88-5 | (3S, 5R)-匹伐他汀钙, ≥98% (3S,5R)-Pitavastatin calcium, ≥98% |
C25H23CaFNO4+ | |
S937877 | 254452-92-1 | (3S,5S)-Pitavastatin calcium, ≥98% (3S,5S)-Pitavastatin calcium, ≥98% |
C25H23CaFNO4+ | |
S936942 | 501121-34-2 | (3S,5S)-阿托伐他汀, ≥95% (3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, ≥95% |
C33H35FN2O5 | |
B794319 | 1270138-40-3 | (4-Benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone, 10mM in DMSO (4-Benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone, 10mM in DMSO |
C22H30N4O | |
M937719 | 2205032-89-7 | (4-tert-butylpiperidin-1-yl)-[4-[hydroxy(diphenyl)methyl]triazol-2-yl]methanone, ≥98% ML-211, ≥98% |
C25H30N4O2 | |
C938094 | 1212663-24-5 | (6S)-6-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-N-propan-2-yl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridine-5-carboxamide, ≥98% CBK289001, ≥98% |
C19H20N6O4 | |
R873577 | 178740-32-4 | (7S,7'R)-双(3,4-亚甲二氧苯基)-rel-(8R,8'R)-二甲基四氢呋喃, ≥98% Rel-(8R,8'R)-dimethyl-(7S,7'R)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan, ≥98% |
C20H20O5 |